Avenue Venture Opportunities Fund, L.P. - 26 Jun 2024 SCHEDULE 13G Report for Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO)

Filing Manager
Avenue Venture Opportunities Fund, L.P.
Reporting Manager
Avenue Capital Management II, L.P.
Security
Cytosorbents Corp Common Stock, par value $0.001 per share
Symbol
CTSO
Shares outstanding
65,881,982 shares
Disclosed Ownership
3,755,273 shares
Ownership
5.7%
Form type
SCHEDULE 13G
Filing time
28 May 2025, 18:47:14 UTC
Date of event
26 Jun 2024
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avenue Venture Opportunities Fund, L.P. 1.7% 1,126,582 0 0 /s/ Andrew Schinder Andrew Schinder Member, GL Venture Opportunities Partners LLC, Man. Member Avenue Venture Opportunities Partners LLC, Gen. Ptnr.
Avenue Venture Opportunities Fund II, L.P. 4% 2,628,691 0 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member GL Venture Opportunities Partners II LLC, Man. Mbr Avenue Venture Opportunities Partners II LLC, Gen. Ptnr.
Avenue Capital Management II, L.P. 5.7% 3,755,273 3,755,273 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member of Avenue Capital Management II GenPar, LLC, General Partner
Avenue Venture Opportunities Partners, LLC 1.7% 1,126,582 0 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member of GL Venture Opportunities Partners, LLC, Managing Member
Avenue Venture Opportunities Partners II, LLC 4% 2,628,691 0 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member of GL Venture Opportunities Partners II, LLC, Managing Member
GL Venture Opportunities Partners, LLC 1.7% 1,126,582 0 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member
GL Venture Opportunities Partners II, LLC 4% 2,628,691 0 0 /s/ Andrew Schinder Andrew Schinder POA for Marc Lasry, Member
Marc Lasry 5.7% 3,755,273 0 0 /s/ Andrew Schinder Marc Lasry Attorney-in-Fact for Marc Lasry